The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection | Annals of the Rheumatic Diseases | 2009 | 1.9K |
The international position on laparoscopic liver surgery: The Louisville Statement, 2008 | Annals of Surgery | 2009 | 1.1K |
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis | Annals of the Rheumatic Diseases | 2009 | 800 |
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal | Annals of the Rheumatic Diseases | 2009 | 543 |
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis | Annals of the Rheumatic Diseases | 2009 | 536 |
Inflammation, growth factors, and pulmonary vascular remodeling | Journal of the American College of Cardiology | 2009 | 518 |
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry | Arthritis and Rheumatism | 2009 | 479 |
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate | Annals of the Rheumatic Diseases | 2009 | 445 |
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research | Annals of the Rheumatic Diseases | 2009 | 410 |
Genome-wide association study identifies three loci associated with melanoma risk | Nature Genetics | 2009 | 360 |
Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials | Annals of the Rheumatic Diseases | 2009 | 356 |
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis | Leukemia | 2009 | 351 |
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS) | Annals of the Rheumatic Diseases | 2009 | 347 |
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative | Annals of the Rheumatic Diseases | 2009 | 320 |
HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies | Arthritis and Rheumatism | 2009 | 298 |
Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies | Rheumatology | 2009 | 289 |
Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival | Journal of Clinical Oncology | 2009 | 280 |
Management of hypertension in angiogenesis inhibitor-treated patients | Annals of Oncology | 2009 | 250 |
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial | Journal of Clinical Endocrinology and Metabolism | 2009 | 242 |
Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects | Chest | 2009 | 232 |
Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase | Human Mutation | 2009 | 225 |
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies | Annals of the Rheumatic Diseases | 2009 | 196 |
Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients | Aids | 2009 | 193 |
The Warburg effect is genetically determined in inherited pheochromocytomas | PLoS ONE | 2009 | 179 |
High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients | Annals of the Rheumatic Diseases | 2009 | 150 |